FAQ/Help |
Calendar |
Search |
Today's Posts |
10-01-2016, 03:26 PM | #1 | ||
|
|||
Member
|
It's for Alzheimer's but may be an early look at Parkinson's
Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease | Georgetown University Medical Center | Georgetown University |
||
Reply With Quote |
10-01-2016, 08:43 PM | #2 | ||
|
|||
Member
|
Quote:
On the good news front, the MJFF/Cure Parkinson's Trust trial will be proceeding, although it won't be until sometime next year. I was with Tom Issacs, the founder of CPT last week and with some of the MJFF research team today. They were all quite confident and positive about the study going forward. Furthermore, while GU's study will be a smaller, one site trial, MJFF intends to have a larger, multi-site study. This will make recruitment easier, and allow a better opportunity for those of us interested to volunteer and participate. Gary |
||
Reply With Quote |
10-01-2016, 09:13 PM | #3 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
10-02-2016, 09:11 PM | #4 | ||
|
|||
Member
|
Tupelo3 said: "no organization would fund them for a PD trial"
I didn't see this information in the article linked to by zanpar321. Do you have a link or a reference that you could share with us? |
||
Reply With Quote |
10-02-2016, 11:37 PM | #5 | ||
|
|||
Member
|
Quote:
They were able to find funding with the ADDF, as stated in the release. They will study 42 AZ patients. Half will get escalating doses of Nilotinib, half will get a placebo. The study primary outcomes will test safety and dosing. Cognitive and functional testing will be secondary tests along with several AZ biomarkers, although, drug efficacy is not the primary outcome . I am told that the GT team would still like to do a PD trial. Sorry, that's all the info I have at this time. |
||
Reply With Quote |
"Thanks for this!" says: |
10-03-2016, 09:36 AM | #6 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
10-03-2016, 07:53 PM | #7 | ||
|
|||
Member
|
As a follow-up to the previous posts, I was told today that GU is still making every attempt to move forward with PD trial simultaneously with the AZ trial. Need to secure the $.
|
||
Reply With Quote |
10-03-2016, 08:42 PM | #8 | ||
|
|||
Member
|
|
||
Reply With Quote |
10-03-2016, 09:39 PM | #9 | ||
|
|||
Member
|
I'm not exactly sure but suspect it has something to do with the break up in negotiations with MJFF/CPT/VARI on the larger combined trial. GU has stated that they are still trying to get Novartis to donate the drug.
|
||
Reply With Quote |
10-03-2016, 10:55 PM | #10 | ||
|
|||
Member
|
Regarding GU's plans for a Nilotinib PD trial, Betsy859 will (hopefully) be able to give us an update next month.
Six month follow up on Nilotinib trial. |
||
Reply With Quote |
"Thanks for this!" says: | zanpar321 (10-04-2016) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
A third clincal trial site for Nilotinib receives FDA approval | Parkinson's Disease | |||
Six month follow up on Nilotinib trial. | Parkinson's Disease |